Literature DB >> 24827451

Variceal hemorrhage: Analysis of 9987 cases from a Japanese nationwide database.

Masaya Sato1, Ryosuke Tateishi, Hideo Yasunaga, Hiromasa Horiguchi, Haruhiko Yoshida, Kiyohide Fushimi, Kazuhiko Koike.   

Abstract

AIM: Gastroesophageal variceal hemorrhage is an important complication of cirrhosis. We investigated the in-hospital mortality and its risk factors after variceal hemorrhage in a large sample population, using a nationwide Japanese database.
METHODS: Data on the patients with variceal hemorrhage were collected for a total of 39 months from a nationwide administrative database covering approximately 1000 hospitals in Japan. The risk factors for fatal outcome after variceal hemorrhage were analyzed with receiver-operator curves (ROC) and univariate and multivariate logistic regression. Comorbidities were assessed with the Charlson Comorbidity Index.
RESULTS: We identified 9987 patients with variceal hemorrhage from a total of 20.3 million inpatients in the database. The median age was 63 years and 68.8% were male. The overall in-hospital mortality was 16.8% (1676 cases). In univariate analysis, Child-Pugh class was the strongest predictor; the area under the ROC of Child-Pugh score for predicting in-hospital mortality was 0.802. In multivariate analysis, increased in-hospital mortality was significantly associated with male sex (vs female: odds ratio [OR] = 1.19, P = 0.01), older age, Child-Pugh class B or C (B vs A: OR = 2.80, P < 0.001; C vs A: OR = 20.1, P < 0.001) and higher Charlson Comorbidity Index (≥6 vs ≤5; OR = 1.29, P < 0.001).
CONCLUSION: In spite of recent advances in the treatment of variceal hemorrhage, the in-hospital mortality remained as high as 16%. Poor liver function was the most important predictor, suggesting that liver failure after variceal hemorrhage might have been the cause of death.
© 2014 The Japan Society of Hepatology.

Entities:  

Keywords:  Child-Pugh score; diagnosis procedure combination; in-hospital mortality; nationwide database; variceal hemorrhage

Year:  2014        PMID: 24827451     DOI: 10.1111/hepr.12357

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  5 in total

1.  Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.

Authors:  Nicholas G Theodorakis; Yining N Wang; Vyacheslav A Korshunov; Mary A Maluccio; Nicholas J Skill
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

2.  Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension.

Authors:  Xinhua Zou; Miao Xue; Jiaping Li
Journal:  Med Sci Monit       Date:  2021-11-29

3.  Endoscopic injection sclerotherapy improves liver function compared with endoscopic variceal ligation.

Authors:  Tsuguru Hayashi; Tatsuyuki Watanabe; Michihiko Shibata; Shinsuke Kumei; Shinji Oe; Koichiro Miyagawa; Yuichi Honma; Masaru Harada
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

4.  Long-term outcomes of patients with cirrhosis presenting with bleeding gastric varices.

Authors:  Manabu Nakazawa; Yukinori Imai; Kayoko Sugawara; Yoshihito Uchida; Yoichi Saitoh; Yohei Fujii; Hiroshi Uchiya; Satsuki Ando; Nobuaki Nakayama; Tomoaki Tomiya; Satoshi Mochida
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

5.  C-reactive Protein Can Predict Patients with Cirrhosis at a High Risk of Early Mortality after Acute Esophageal Variceal Bleeding.

Authors:  Takeshi Ichikawa; Nobuaki Machida; Hiroaki Kaneko; Itaru Oi; Masayuki A Fujino
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.